Page 165 - 2021_10-Haematologica-web

Genetic landscape of plasmablastic lymphoma
expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-indepen- dent survival pathway closely associated with Stat3 activation. Blood. 2004;103(1): 242-251.
44.Mine S, Hishima T, Suganuma A, et al. Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets. Sci Rep. 2017;7(1):10188.
45.Grande BM, Gerhard DS, Jiang A, et al. Genome-wide discovery of somatic coding and non-coding mutations in pediatric
endemic and sporadic Burkitt lymphoma.
Blood. 2019;133(12):1313-1324.
46. Zhou Y, Xu Z, Lin W, et al. Comprehensive
genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes. Front Oncol. 2019;9:683.
47. Menter T, Juskevicius D, Alikian M, et al. Mutational landscape of B-cell post-trans- plant lymphoproliferative disorders. Br J Haematol. 2017;178(1):48-56.
48. Yoon H, Park S, Ju H, et al. Integrated copy number and gene expression profiling analy-
sis of Epstein-Barr virus-positive diffuse large B-cell lymphoma. Genes Chromosomes Cancer. 2015;54(6):383-396.
49.Zhu F, Wang KB, Rui L. STAT3 activation and oncogenesis in lymphoma. Cancers (Basel). 2019;12(1):19.
50. Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{k}B pathways in sub- types of diffuse large B-cell lymphoma. Blood. 2008;111(7):3701-3713.
haematologica | 2021; 106(10)
2693